Persistence on monthly zoledronic acid impacts risk and frequency of skeletal complications and follow-up duration in lung cancer patients

被引：0
|
作者：
Hatoum, Hind T. [1 ,2 ]
Lin, Swu-Jane [1 ,2 ]
Lipton, Allan [3 ]
Guo, Amy [4 ]
Smith, Matthew R. [5 ]
机构：
[1] Hind T Hatoum & Co, Chicago, IL USA
[2] Univ Illinois, Chicago, IL USA
[3] Hershey Med Ctr, Hershey, PA USA
[4] Novartis Pharmaceut, Florham Pk, NJ USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S432 / S433
页数：2
相关论文
共 50 条
  • [1] Effect of adherence to monthly zoledronic acid treatment on risk and frequency of skeletal complications and follow-up duration in breast cancer patients
    Hatoum, H. T.
    Lin, S.
    Smith, M. R.
    Lipton, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis
    Hatoum, Hind T.
    Lin, Swu-Jane
    Guo, Amy
    Lipton, Allan
    Smith, Matthew R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 55 - 62
  • [3] Timing of zoledronic acid treatment impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis
    Hatoum, H. T.
    Lin, S.
    Smith, M. R.
    Guo, A.
    Lipton, A.
    BONE, 2010, 47 : S309 - S309
  • [4] Treatment Persistence With Monthly Zoledronic Acid is Associated With Lower Risk and Frequency of Skeletal Complications in Patients With Breast Cancer and Bone Metastasis
    Hatoum, Hind T.
    Lin, Swu-Jane
    Smith, Matthew R.
    Guo, Amy
    Lipton, Allan
    CLINICAL BREAST CANCER, 2011, 11 (03) : 177 - 183
  • [5] Impact of zoledronic acid on follow-up duration in lung cancer patients with bone metastasis in a US managed care plan
    Kaura, S.
    Thayer, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 523 - 523
  • [6] The impact of zoledronic acid treatment on frequency of skeletal complications experienced and on followup duration post diagnosis of bone metastasis in lung cancer patients
    Hatoum, H. T.
    Lin, S.
    Lipton, A.
    Barghout, V.
    Mody-Patel, N.
    Smith, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] FOLLOW-UP DATA OF PATIENTS WITH OSTEOPOROSIS RECEIVING ZOLEDRONIC ACID
    Yilmaz, F.
    Kuran, B.
    Dogu, B.
    Oncu, J.
    Duman, Z.
    Ercalik, C.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S457 - S457
  • [8] The Follow-up of Patients with Lung Cancer
    Tufman, Amanda
    Duell, Thomas
    Schneider, Christian
    ZENTRALBLATT FUR CHIRURGIE, 2019, 144 (01): : 106 - 117
  • [9] FOLLOW-UP OF PATIENTS WITH LUNG-CANCER
    WEBER, J
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1982, 37 (32): : 1422 - 1424
  • [10] Zoledronic acid is superior to pamidronate in patients with breast cancer and multiple myeloma: analysis of patients at high risk for skeletal complications
    Conte, PierFranco
    Rosen, Lee S.
    Gordon, David
    Zheng, Ming
    Hei, Yong-Jiang
    ANNALS OF ONCOLOGY, 2004, 15 : 124 - 124
12345